STAREE statin trial in 10,000 people over 70 is complete; no major harm or big benefit
Louis explains that STAREE (atorvastatin 40 mg versus placebo in healthy adults 70+, focused on disability-free survival including dementia) is finished and will report soon. Because it was not stopped early for harm or overwhelming benefit, results likely lie in between.
